CrystalGenomics Invites Co Ltd

XKRX:083790 (Korea (the Republic of))   Ordinary Shares
â‚© 2435.00 (+3.18%) Nov 29
At Loss
P/B:
1.60
Market Cap:
â‚© 187.24B ($ 134.29M)
Enterprise V:
â‚© 187.38B ($ 134.39M)
Volume:
152.51K
Avg Vol (2M):
272.72K
Trade In:
Volume:
152.51K
At Loss
Avg Vol (2M):
272.72K

Business Description

Description
CrystalGenomics Invites Co Ltd Formerly CrystalGenomics Inc is one of the leading biopharmaceutical company in Korea. The company is mainly engaged in the research and development and new drug development. It develops innovative new drug development projects such as eradication antibiotics and molecular targeted anticancer drugs. It focuses on arthritic medicines and antibiotics which kill resistant bacteria. It also offers medicines for cancer, obesity, asthma, and diabetes.
Name Current Vs Industry Vs History
Cash-To-Debt 1
Equity-to-Asset 0.52
Debt-to-Equity 0.33
Debt-to-EBITDA -0.7
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.23
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 38.29
9-Day RSI 40.59
14-Day RSI 44.3
6-1 Month Momentum % 2.81
12-1 Month Momentum % -2.66

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.78
Quick Ratio 0.74
Cash Ratio 0.64
Days Inventory 189.6
Days Sales Outstanding 110.92
Days Payable 189.03

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.4
Shareholder Yield % 21.37
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

CrystalGenomics Invites Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil â‚©) 5,573.976
EPS (TTM) (â‚©) -801
Beta 1.37
Volatility % 45.14
14-Day RSI 44.3
14-Day ATR (â‚©) 149.507814
20-Day SMA (â‚©) 2558.25
12-1 Month Momentum % -2.66
52-Week Range (â‚©) 2015 - 4385
Shares Outstanding (Mil) 76.89

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CrystalGenomics Invites Co Ltd Filings

Filing Date Document Date Form
No Filing Data

CrystalGenomics Invites Co Ltd Stock Events

Financials Calendars
Event Date Price(â‚©)
No Event Data

CrystalGenomics Invites Co Ltd Frequently Asked Questions

What is CrystalGenomics Invites Co Ltd(XKRX:083790)'s stock price today?
The current price of XKRX:083790 is â‚©2435.00. The 52 week high of XKRX:083790 is â‚©4385.00 and 52 week low is â‚©2015.00.
When is next earnings date of CrystalGenomics Invites Co Ltd(XKRX:083790)?
The next earnings date of CrystalGenomics Invites Co Ltd(XKRX:083790) is .
Does CrystalGenomics Invites Co Ltd(XKRX:083790) pay dividends? If so, how much?
CrystalGenomics Invites Co Ltd(XKRX:083790) does not pay dividend.

Press Release

Subject Date
No Press Release